Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, September 30 2014 11:55am ET - U.S. Markets close in 4 hours and 5 minutes.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Diagnostic Substances News
Latest News
Monday, Sep 29, 2014
·Amag Pharma enters women health business with $675 mln deal
Reuters - Mon 2:33 pm ET
·Why AMAG Pharmaceuticals (AMAG) Stock Is Up Today
at - Mon 11:22 am ET
·Amag, Perrigo Buy Lumara in Two-Step Deal Valued at $1.1B
at - Mon 11:13 am ET
·Lumara Health to sell assets to AMAG, Perrigo for $757 million
at MarketWatch - Mon 8:31 am ET
·[$$] Lumara Health to Sell Assets
at The Wall Street Journal Online - Mon 8:19 am ET
·Amag Pharma buys women's health company Lumara for $675 mln
Reuters - Mon 7:23 am ET
·Lumara Healthâ„¢ to be Acquired in Two Separate Transactions for up to $1.107 Billion
PR Newswire - Mon 7:15 am ET
·AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business
GlobeNewswire - Mon 6:55 am ET
Thursday, Sep 25, 2014
·Trinity Biotech Announces CE Marking of New Meritas Heart Failure (BNP) Point-of-Care Test
GlobeNewswire - Thu Sep 25
Wednesday, Sep 24, 2014
·Why Atossa Genetics (ATOS) Stock Hit a One-Year Low Today
at - Wed Sep 24
Tuesday, Sep 23, 2014
·Atossa Genetics Inc. Provides Regulatory and Commercial Update on Its ForeCYTE Breast Aspirator and Its FullCYTE Breast Aspirator
Marketwire - Tue Sep 23
Monday, Sep 22, 2014
·Neogen reports 13% net income increase
PR Newswire - Mon Sep 22
Friday, Sep 19, 2014
·[video] What to Watch on Wall Street for Monday, September 22nd 2014
at - Fri Sep 19
·Is a Surprise Coming for Neogen (NEOG) This Earnings Season? - Fri Sep 19
Thursday, Sep 18, 2014
·IDEXX Laboratories Names Jacqueline L. Studer Corporate Vice President and General Counsel
PR Newswire - Thu Sep 18
·Merck Animal Health to market Neogen's dairy genomic program
PR Newswire - Thu Sep 18
Tuesday, Sep 16, 2014
·AMAG Pharmaceuticals Appoints Judith Johnson, M.D. as Vice President of Pharmacovigilance and Pharmacoepidemiology
GlobeNewswire - Tue Sep 16
Friday, Sep 12, 2014
·Accelerating the Adoption Curve: Improving Patient Outcomes in Psychiatry
GlobeNewswire - Fri Sep 12
Thursday, Sep 11, 2014
·CONX: Record Revenue in Q4 and Fiscal 2014
- Thu Sep 11
Wednesday, Sep 10, 2014
·Nymox Announces Positive Prostate Cancer 8 Month Clinical Trial Results
GlobeNewswire - Wed Sep 10
More Latest News...
Sponsor Results
INOGEN G2 UpGraded Oxygen
#1 Lowest Verified Price in USA. Newest Inogen. Free Next-Day FedEx
Surgical Video Equipment
Huge Selection & Low Prices on Surgical Microscope Video Equipment
2014's Top Medical Alerts
View Our Side By Side Comparison Of 2014's Best Medical Alert Buttons!
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?